Ocular preservation after 36 Gy external beam radiation therapy for retinoblastoma

Thomas E. Merchant, Ciara J. Gould, Nathan E. Hilton, Larry E. Kun, Carlos Rodríguez-Galindo, Charles B. Pratt, Matthew Wilson, Barrett Haik

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Purpose: The purpose of this study was to document the ocular preservation rate after 36 Gy external beam radiation therapy (EBRT) for retinoblastoma. Patients and Methods: Forty-nine eyes of 38 patients were treated with a median dose of 36 Gy EBRT. The patient population included 7 unilateral and 31 bilateral presentations, with a median age at diagnosis of 4 months. Eyes enucleated at the time of diagnosis or treated with other measures were not included in the analysis of ocular preservation. The median age at EBRT was 8 months. Patients were monitored for progression of disease after EBRT and second malignant neoplasms. Results: The median follow-up was 88.6 months, with an estimated ocular preservation rate of 82.0% ± 5% at 10 years. There was a difference in the ocular preservation rates for patients with advanced disease (Reese-Ellsworth group III-V) compared with early disease. Metastatic disease developed in two patients, and a second malignant neoplasm developed in three. Patients treated with en face electrons experienced a lower 5-year estimate of ocular preservation than those treated with photons, although patients treated with electrons were more likely to have advanced disease. Conclusions: The use of low-dose EBRT (36 Gy) results in ocular preservation rates that are comparable to those of high-dose EBRT. The use of electrons requires careful treatment planning and computerized dosimetry.

Original languageEnglish (US)
Pages (from-to)246-249
Number of pages4
JournalJournal of Pediatric Hematology/Oncology
Volume24
Issue number4
DOIs
StatePublished - 2002

Fingerprint

Retinoblastoma
Radiotherapy
Second Primary Neoplasms
Electrons
Photons
Disease Progression

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Pediatrics, Perinatology, and Child Health

Cite this

Merchant, T. E., Gould, C. J., Hilton, N. E., Kun, L. E., Rodríguez-Galindo, C., Pratt, C. B., ... Haik, B. (2002). Ocular preservation after 36 Gy external beam radiation therapy for retinoblastoma. Journal of Pediatric Hematology/Oncology, 24(4), 246-249. https://doi.org/10.1097/00043426-200205000-00005

Ocular preservation after 36 Gy external beam radiation therapy for retinoblastoma. / Merchant, Thomas E.; Gould, Ciara J.; Hilton, Nathan E.; Kun, Larry E.; Rodríguez-Galindo, Carlos; Pratt, Charles B.; Wilson, Matthew; Haik, Barrett.

In: Journal of Pediatric Hematology/Oncology, Vol. 24, No. 4, 2002, p. 246-249.

Research output: Contribution to journalArticle

Merchant, TE, Gould, CJ, Hilton, NE, Kun, LE, Rodríguez-Galindo, C, Pratt, CB, Wilson, M & Haik, B 2002, 'Ocular preservation after 36 Gy external beam radiation therapy for retinoblastoma', Journal of Pediatric Hematology/Oncology, vol. 24, no. 4, pp. 246-249. https://doi.org/10.1097/00043426-200205000-00005
Merchant, Thomas E. ; Gould, Ciara J. ; Hilton, Nathan E. ; Kun, Larry E. ; Rodríguez-Galindo, Carlos ; Pratt, Charles B. ; Wilson, Matthew ; Haik, Barrett. / Ocular preservation after 36 Gy external beam radiation therapy for retinoblastoma. In: Journal of Pediatric Hematology/Oncology. 2002 ; Vol. 24, No. 4. pp. 246-249.
@article{114e9d08e1eb47ea97d3bb298124e064,
title = "Ocular preservation after 36 Gy external beam radiation therapy for retinoblastoma",
abstract = "Purpose: The purpose of this study was to document the ocular preservation rate after 36 Gy external beam radiation therapy (EBRT) for retinoblastoma. Patients and Methods: Forty-nine eyes of 38 patients were treated with a median dose of 36 Gy EBRT. The patient population included 7 unilateral and 31 bilateral presentations, with a median age at diagnosis of 4 months. Eyes enucleated at the time of diagnosis or treated with other measures were not included in the analysis of ocular preservation. The median age at EBRT was 8 months. Patients were monitored for progression of disease after EBRT and second malignant neoplasms. Results: The median follow-up was 88.6 months, with an estimated ocular preservation rate of 82.0{\%} ± 5{\%} at 10 years. There was a difference in the ocular preservation rates for patients with advanced disease (Reese-Ellsworth group III-V) compared with early disease. Metastatic disease developed in two patients, and a second malignant neoplasm developed in three. Patients treated with en face electrons experienced a lower 5-year estimate of ocular preservation than those treated with photons, although patients treated with electrons were more likely to have advanced disease. Conclusions: The use of low-dose EBRT (36 Gy) results in ocular preservation rates that are comparable to those of high-dose EBRT. The use of electrons requires careful treatment planning and computerized dosimetry.",
author = "Merchant, {Thomas E.} and Gould, {Ciara J.} and Hilton, {Nathan E.} and Kun, {Larry E.} and Carlos Rodr{\'i}guez-Galindo and Pratt, {Charles B.} and Matthew Wilson and Barrett Haik",
year = "2002",
doi = "10.1097/00043426-200205000-00005",
language = "English (US)",
volume = "24",
pages = "246--249",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Ocular preservation after 36 Gy external beam radiation therapy for retinoblastoma

AU - Merchant, Thomas E.

AU - Gould, Ciara J.

AU - Hilton, Nathan E.

AU - Kun, Larry E.

AU - Rodríguez-Galindo, Carlos

AU - Pratt, Charles B.

AU - Wilson, Matthew

AU - Haik, Barrett

PY - 2002

Y1 - 2002

N2 - Purpose: The purpose of this study was to document the ocular preservation rate after 36 Gy external beam radiation therapy (EBRT) for retinoblastoma. Patients and Methods: Forty-nine eyes of 38 patients were treated with a median dose of 36 Gy EBRT. The patient population included 7 unilateral and 31 bilateral presentations, with a median age at diagnosis of 4 months. Eyes enucleated at the time of diagnosis or treated with other measures were not included in the analysis of ocular preservation. The median age at EBRT was 8 months. Patients were monitored for progression of disease after EBRT and second malignant neoplasms. Results: The median follow-up was 88.6 months, with an estimated ocular preservation rate of 82.0% ± 5% at 10 years. There was a difference in the ocular preservation rates for patients with advanced disease (Reese-Ellsworth group III-V) compared with early disease. Metastatic disease developed in two patients, and a second malignant neoplasm developed in three. Patients treated with en face electrons experienced a lower 5-year estimate of ocular preservation than those treated with photons, although patients treated with electrons were more likely to have advanced disease. Conclusions: The use of low-dose EBRT (36 Gy) results in ocular preservation rates that are comparable to those of high-dose EBRT. The use of electrons requires careful treatment planning and computerized dosimetry.

AB - Purpose: The purpose of this study was to document the ocular preservation rate after 36 Gy external beam radiation therapy (EBRT) for retinoblastoma. Patients and Methods: Forty-nine eyes of 38 patients were treated with a median dose of 36 Gy EBRT. The patient population included 7 unilateral and 31 bilateral presentations, with a median age at diagnosis of 4 months. Eyes enucleated at the time of diagnosis or treated with other measures were not included in the analysis of ocular preservation. The median age at EBRT was 8 months. Patients were monitored for progression of disease after EBRT and second malignant neoplasms. Results: The median follow-up was 88.6 months, with an estimated ocular preservation rate of 82.0% ± 5% at 10 years. There was a difference in the ocular preservation rates for patients with advanced disease (Reese-Ellsworth group III-V) compared with early disease. Metastatic disease developed in two patients, and a second malignant neoplasm developed in three. Patients treated with en face electrons experienced a lower 5-year estimate of ocular preservation than those treated with photons, although patients treated with electrons were more likely to have advanced disease. Conclusions: The use of low-dose EBRT (36 Gy) results in ocular preservation rates that are comparable to those of high-dose EBRT. The use of electrons requires careful treatment planning and computerized dosimetry.

UR - http://www.scopus.com/inward/record.url?scp=0036249998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036249998&partnerID=8YFLogxK

U2 - 10.1097/00043426-200205000-00005

DO - 10.1097/00043426-200205000-00005

M3 - Article

VL - 24

SP - 246

EP - 249

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 4

ER -